Botanix Ltd CEO Dr Howie McKibbon sits down with Proactive's Tylah Tully live from the ASX Small and Mid Cap Conference in September 2024.
Chaired by Phoenix-based pharmaceutical magnate Vince Ippolito, the company is on a mission to create innovative solutions for common (yet overlooked) skin diseases and infections.
Amid growing demand for these kinds of treatments, Botanix has assembled a team of dermatology, clinical research and commercialisation experts to further its portfolio.
According to Dr McKibbon, the company wants to use its clinical expertise to deliver first-in-class treatments at the highest industry standards.